Hi Aksier,
It surprising that SLA could have announced the results of the trial in October 2006, when the trials were still going in 2007. From yesterdays alcoholics trial, "The Directors of Solagran Limited are pleased to provide a summary of the results of the Ropren® clinical trials conducted at the Skvortsova-Stepanova psychiatric hospital in 2006-07 with serious and critically ill, drug addicted chronic alcoholics".
C'mon, be a big person, apologise to the thread for misleading them. Denis's own words are beating you up. It's easy and it will allow you to get past your mistake.
Cheers,
Bill
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
23.5¢ |
Change
0.030(14.6%) |
Mkt cap ! $13.91M | |||
| Open | High | Low | Value | Volume |
| 22.0¢ | 25.0¢ | 22.0¢ | $139.6K | 617.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 100000 | 23.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 24.0¢ | 50000 | 1 |
View Market Depth
| Last trade - 15.55pm 22/07/2025 (20 minute delay) ? |
| SLA (ASX) Chart |